|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-6-7
|
|
pubmed:abstractText |
Percutaneous coronary intervention (PCI) to palliate cardiac allograft vasculopathy (CAV) has been associated with high restenosis rates, possibly related to increased inflammation associated with this disease. Whether markers of immunologic rejection are associated with restenosis in this population is unknown. The goal of the study was to determine the predictors of restenosis after PCI for CAV.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1581-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15940049-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15940049-Autoantibodies,
pubmed-meshheading:15940049-Biopsy,
pubmed-meshheading:15940049-Coronary Angiography,
pubmed-meshheading:15940049-Coronary Artery Bypass,
pubmed-meshheading:15940049-Coronary Restenosis,
pubmed-meshheading:15940049-Coronary Stenosis,
pubmed-meshheading:15940049-Follow-Up Studies,
pubmed-meshheading:15940049-HLA Antigens,
pubmed-meshheading:15940049-Heart Transplantation,
pubmed-meshheading:15940049-Humans,
pubmed-meshheading:15940049-Retrospective Studies,
pubmed-meshheading:15940049-Stents,
pubmed-meshheading:15940049-Survival Analysis,
pubmed-meshheading:15940049-Time Factors,
pubmed-meshheading:15940049-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy.
|
|
pubmed:affiliation |
Division of Cardiology, Columbia University, New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article
|
